International Clinical Trial: Clinical Study of Etoposide Soft Capsules Combined with Immune Checkpoint Inhibitors as Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer without Disease Progression After First-Line Chemoimmunotherapy

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119676) titled 'Clinical Study of Etoposide Soft Capsules Combined with Immune Checkpoint Inhibitors as Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer without Disease Progression After First-Line Chemoimmunotherapy' on March 2.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Army Medical Center of PLA

Condition: Extensive-Stage Small Cell Lung Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-15

Target Sample Size: Experimental group:49;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showpro...